Dr. Choe's CV - University of South Florida

May 31, 2013
CURRICULUM VITAE
ULYEE CHOE, DO
Polk County Health Department
1290 Golfview Avenue, 4 th Floor
Bartow, FL 33830
1 Tampa General Circle
Tampa, FL 33606
(813) 844-4187 Office
(813) 844-7605 Fax
uchoe@health.usf.edu
EDUCATION
Nova Southeastern University College of Osteopathic Medicine,
Ft. Lauderdale, FL
Doctor of Osteopathic Medicine, 5/2005
University of Florida, Gainesville, FL
Bachelor of Science 5/2001 with Honors
Major: Microbiology
POSTGRADUATE TRAINING
Fellowship, Infectious Disease and International Medicine
University of South Florida, Tampa: 7/2009 – 6/2011
Residency, Internal Medicine
University of South Florida, Tampa: 7/2006 – 6/2009
Rotating Internship, Northside Hospital and Heart Institute
St. Petersburg, FL: 7/2005 – 6/2006
MEDICAL LICENSURE
Florida, OS10735
CERTIFICATIONS
Diplomate, American Board of Internal Medicine, Infectious Disease: 10/2011
Diplomate, American Board of Internal Medicine: 8/2009
Advanced Cardiac Life Support, Certification: 4/2011
Basic Life Support, Certification: 4/2013

ACADEMIC POSITIONS
Assistant Professor of Medicine, University of South Florida College of
Medicine, Division of Infectious Disease and International Medicine, Tampa:
2011 - present
Faculty, Section of Infectious Disease, James A. Haley Veterans Hospital, Tampa:
2011-2013
ADMINISTRATIVE POSITIONS
Director, Polk County Health Department, Bartow: 5/2013 - present
Interim Director, Polk County Health Department, Bartow: 11/2012 – 5/2013
Chairman, Health and Medical Committee of the Eight County Tampa Bay
Regional Domestic Security Task Force: 2012 - present
HONORS AND AWARDS
ECSS Awardee for Educational Excellence 2011/12, Office of Education,
University of South Florida: 2012
Gold Star Award for Outstanding Customer Service, James A. Haley Veterans
Hospital, Tampa: 2011
Traveler’s Grant, Poster presentation at Infectious Disease Society of America,
Boston, MA: 2011
Chief Fellow of Infectious Disease, University of South Florida, Tampa: 2010 –
2011
Chief Resident of Internal Medicine, University of South Florida, Tampa: 2008
Outstanding Third Year Resident, Internal Medicine, University of South Florida,
Tampa: 2009
Outstanding First Year Resident, Internal Medicine, University of South Florida,
Tampa: 2007
EDUCATIONAL ACTIVITIES
Preceptor/Liaison for Yeungnam Medical School, South Korea, University of
South Florida, Tampa: 1/2012 – present
Board Review Lecture Series in Infectious Disease and International Medicine,
University of South Florida, Tampa: 2012 – present

Scholarly Concentration in Research for Medical Students, University of South
Florida, USF Health, Tampa: 2012
Bloodborne Pathogen: Biosafety CORE course, presenter, University of South
Florida, Tampa: 2011
Medical Student Case Conferences, Instructor, University of South Florida,
Tampa: 2008
PUBLICATIONS
Choe U, Oller K, Casanas, B. An Unusual Case of Toxoplasmosis Presenting as a
Cecal Mass. Awaiting publication.
Kunadharaju R, Choe U, Harris J, et al. Case report: Cryptococcus gattii –
Emerging fungal pathogen in Florida. Emerg Infect Dis 2013; 19(3): 519-21.
Carrington M, Choe U, Ubilos S, et al. Fatal Case of Brucellosis Misdiagnosed in
Early Stages of Brucella.suis Infection in a 46-year-old Patient with Marfan
Syndrome. J Clin Microbiol 2012; 50 (6): 2173-5.
Gompf SG, Smith K, Choe U. Arenaviruses. eMedicine at WebMD. 2011.
Available at: http://emedicine.medscape.com/article/212356-overview
Choe U. HPV Vaccine Recommendations. Florida/Caribbean AIDS Education
and Training Center HIV Carelink. 2011; 12 (2).
ABSTRACTS/PRESENTATIONS
Choe U, Nasr G, Shah M, et al. HIV Virologic Outcomes in Associated with
Ritonavir-boosted Atazanavir and Concomitant Acid Suppressive Therapy.
Poster presented at Infectious Disease Society of America, Boston, MA. October
2011
Carrington M, Choe U, Stanek D, et al. A fatal case of brucellosis misdiagnosed
in early stages of B. suis infection in a 46-year-old patient with Marfan syndrome.
Poster presented at: 64 th Brucellosis Research Conference, Buenos Aires,
Argentina. September 2011
Choe U. HIV Treatment Strategies. Presentation at the HIV Intensive Course at
the Southeast STD/HIV Prevention Training Center, Tampa, FL. October 2010
Choe U. HIV Virologic Outcomes in Associated with Ritonavir-boosted
Atazanavir and Concomitant Acid Suppressive Therapy. Presentation at Florida
Infectious Disease Society Meeting; Orlando, FL. June 2010

Franck R, Choe U, Montero J. A case of coccidioidomycosis presenting as
military tuberculosis. Poster presented at: The American College of Physicians;
Tampa, FL Sept 2007
RESEARCH
Protocols (Co-Investigator)
A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy
of GS-9350-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each
Administered with Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1
Infected, Antiretroviral Treatment-Naïve Adults
A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy
of Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate/GS-9350 Versus
Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate
in HIV-1 Infected, Antiretroviral Treatment-Naïve Adults
A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy
of Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate/GS-9350 Versus
Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected,
Antiretroviral Treatment-Naïve Adults
A Phase 2, A Phase 2, Open-Label, Multicenter Study of the Safety of Ritonavir-
Boosted GS 9137 GS 9137/r) Administered in Combination with Other
Antiretroviral Agents for the Treatment of HIV 1 Infected Subjects.
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of a Novel
CCR5 Antagonist, UK-427,857, in Combination with Optimized Background
Therapy versus Optimized Background Therapy along for the Treatment of
Antiretroviral-Experienced HIV-1 Infected Subjects. [Pfizer A4001027]
A randomized, controlled, partially blinded Phase IIb dose-finding trial of
TMC125, in HIV-1 infected subjects with documented genotypic evidence of
resistance to currently available NNRTIs and with at least three primary PI
mutations. [TMC125-C223]
A Phase II, Randomized, Blinded, 12-Week Comparison of Elvucitabine in
Combination with Efavirenz and Tenofoxvir Versus Lamivudine in Combination
with Efavirenz and 4 Tenofovir in HIV-1 Infected, Treatment-Naïve Subjects,
with a 12-Week Extension Treatment Period. [ACH443-015]
A Large, Simple Trial Comparing Two Strategies for Management of Anti-
Retroviral Therapy. [SMART CPCRA 065]

A randomized, controlled, open-label trial to compare the efficacy, safety and
tolerability of TMC114/ritonavir versus lopinavir/ritonavir in treatment-naïve
HIV-1 infected subjects. This trial will be referred to as ARTEMIS. [TMC114-
211]
A Phase IIb, Randomized, Partially Blinded, Dose-Finding Trial of TMC278 in
Antiretroviral Naïve HIV-1 Infected Subjects. [TMC278-204]
An Open-Label Trial with TMC125 in HIV-1 Infected Subjects, Who Were
Randomized to a TMC125 Treatment Arm in a Sponsor-Selected TMC125 Trial
and were Treated for at least 48 Weeks. [TMC125-C229]
A 96-Week, Phase IV, Randomized, Double-Blind, Multicenter Study of the
Safety and Efficacy of Epzicom Versus Truvada Administered in Combination
with Kaletra in Antiretroviral-Naive HIV-1 Infected Subjects. [EPZ104057] –
HEAT
A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two
Doses of GW433908/Ritonavir Given with Abacavir/Lamivudine Fixed Dose
Combination. [COL100758]
A Probe Study to Evaluate the Safety, Tolerability, and Immunogenicity of the
MRK Adenovirus Serotype 5 Vector (MRKAd5) Human Immunodeficiency
Virus Type I (HIV-1) gag Vaccine in HIV-1 Infected Individuals. [Merck V520 –
014]
A Randomized, Controlled, Open-Trial to Compare the Efficacy, Safety and
Tolerability of TMC114/RTV versus LPV/RTV in Treatment-Experienced HIV-1
Infected Subjects. [TMC114-C214]
COMMITTEES/PROFESSIONAL ACTIVITIES
Member, Institutional Biosafety Committee, University of South Florida, 2011 –
present
Developer, Laboratory Exposure Identification Protocol, University of South
Florida, Tampa: 2011
Laboratory Biosafety and Exposures, Division of Infectious Disease, University
of South Florida, Tampa: 2011 – 2012
Shigella Outbreak Investigator, Hillsborough County Health Department, Tampa:
2010
World’s AIDS Day, presenter and organizer, Hillsborough County Health
Department, Tampa: 2010
Member, Infection Control, Tampa General Hospital, Tampa: 2012

STD Clinic Consultation, Hillsborough County Health Department, Tampa: 2009
- 2012
Quality Assurance Specialty Care Clinic, Hillsborough County Health
Department, Tampa: 2009 – 2011
World’s AIDS Day, developed program to increase public awareness of HIV and
STI using social media, Hillsborough County Health, Tampa: 2009
Member, Internal Medicine Residency Selection Committee, University of South
Florida, Tampa: 2009
Member, Internal Medicine Disciplinary Committee, University of South Florida,
Tampa: 2008
CURRENT HOSPITAL/CLINIC AFFLIATIONS
Specialty Care Unit/ Adult Health Clinic, Polk County Health Department,
Bartow, FL, 2012 - present
Consultant, Tampa General Healthcare, Tampa, FL, 2011 – present
Consultant, James A. Haley VA Hospital, Tampa, FL, 2011 – 2012
Consultant, H. Lee Moffitt, Tampa, FL, 2011 - present
PROFESSIONAL SOCIETIES
Polk County Medical Association, Executive Committee, Public Health Chairman
Infectious Disease Society of America
Florida Infectious Disease Society
American College of Physicians
DOCARE International
American Osteopathic Association
COMMUNITY ORGANIZATIONS
United Way, Health Steering Committee
Homeless Youth Task Force
Polk Vision
WORK EXPERIENCE
James A Haley VA Hospital Compensation and Pension
Tampa, FL, 2011

KLM Medical Services, Social Security Disability Examinations
Tampa, FL, 11/2009 – 6/2010
Teaching Assistant for Molecular Biology
University of Florida, Gainesville, FL, 1/2001 – 5/2001
Pharmacy Technician
Albertsons, Clearwater, FL, 5/1999 – 8/1999
Laboratory Technician
University of Florida, Gainesville, FL, 5/1998 – 8/1998
COMMUNITY / MEDIA / EXTRACURRICULAR ACTIVITIES
“Obesity Awareness” Polk Place: Polk Government Television
Bartow, FL 9/2012
“Fall Public Health Update on West Nile Virus and Influenza” Polk Place: Polk
Government Television
Bartow, FL 8/2012
“An Update on HIV-2” University of South Florida Infectious Disease Podcast,
3/2012
“Procalcitonin: Fact or Fiction” University of South Florida Infectious Disease
Podcast, 3/2012
DOCARE International Medical Mission
Guatemala, 1/2003 – 6/2002
Bell Glade Health Fair
Bell Glade, FL, 2/2002
Hospice of North Central Florida
Gainesville, FL, 6/1999 – 5/2001
Arts in Medicine
Shands Hospital, Gainesville, FL, 6/1998 – 5/2001